NCT05304637View on ClinicalTrials.gov

Usability, Immediate, and 30 Day Effect of External Neuromodulation With iTEAR100 Generation 2 in Dry Eye Patients

PHASE4UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

June 1, 2022

Study Completion Date

July 1, 2022

Conditions
Dry Eye
Interventions
DEVICE

iTEAR100 treatment

Vibratory energy to the external nasal nerve

Trial Locations (2)

98027

RECRUITING

Olympic Ophthalmics, Issaquah

98119

RECRUITING

Periman Eye Institute, Seattle

Sponsors
All Listed Sponsors
lead

Olympic Ophthalmics, Inc.

INDUSTRY

NCT05304637 - Usability, Immediate, and 30 Day Effect of External Neuromodulation With iTEAR100 Generation 2 in Dry Eye Patients | Biotech Hunter | Biotech Hunter